Valeda Light Delivery System

The First and Only Treatment for Dry Age-Related
Macular Degeneration (AMD) to Improve Vision

Dry Age-Related Macular Degeneration

AMD is a progressive disease of the retina, the part of the eye that detects visual signals and sends them to the brain. It is the leading cause of vision loss in people over 65, and there is no cure.

The dry form accounts for 85 to 90% of AMD cases.

No More Watch and Wait: Treat With Valeda™ PBM

The first and only ValedaTM PBM is the first and only FDA-authorized treatment for early and intermediate dry AMD
Improve and maintain vision 84% of ValedaTM PBM–treated patients improved or maintained vision at ~2 years compared to baseline
A noninvasive and smooth patient experience Dilation free, speculum free, anesthesia free, and injection free

Consistent Safety in Multiple Clinical Trials

ValedaTM PBM delivers proven efficacy in dry AMD with a favorable safety profile.

0 reports of phototoxicity in 3 LIGHTSITE trials
>97% of patients did not report eye pain

Benefits of Valeda Treatment

Treatment with Valeda can help you see more clearly now and in the future. Retinal imaging indicates improvement in eye scans when assessed for drusen (protein deposits observed in eyes with dry AMD).

How Valeda Works

Valeda uses photobiomodulation (PBM), specific wavelengths of low- level light therapy, to stimulate energy production within the eye, resulting in improved cellular health. Healthy retinal cells are essential for maintaining good vision.

Preparing for Your Valeda Treatment

No special preparation is needed before treatment. You will need to remove glasses or contact lenses. There are no eye drops, drugs, or needles used in the treatment. There is no discomfort during or after the treatment.

During Your Valeda Treatment

You will be seated comfortably in front of Valeda and guided through each step of the treatment. The active treatment time is less than 5 minutes per eye per session.

You will receive 9 treatments over 3 to 5 weeks during each series. Typically, a series is repeated every 4 months. Your doctor will determine your plan.

After Your Valeda Treatment

Due to the exposure to bright lights, you may experience an afterimage following treatment. This is known as photostress. Normal photostress recovery time is approximately 15-30 seconds. Following treatment, you will be able to resume normal activities.

Valeda Safety

There have been no treatment-related side effects in clinical trials with Valeda.
Consult your eye doctor for an explanation of the benefits and risks associated with Valeda treatment.
Valeda is authorized by the U.S. Food & Drug Administration (FDA) and is available by prescription only.

Valeda Indications for Use

The Valeda Light Delivery System is intended to provide improved visual acuity in patients with best-corrected visual acuity of 20/32 through 20/70 and who have dry age- related macular degeneration (AMD) characterized by:

The presence of at least 3 medium drusen (> 63 μm and ≤ 125 μm in diameter), or large drusen (> 125 μm in diameter), or non-central geographic atrophy, AND
The absence of neovascular maculopathy or center-involving geographic atrophy

After about two years, the Valeda Light Delivery System treatment provides improved mean visual acuity of approximately one line of visual acuity (ETDRS) compared to those not receiving the
treatment.

Contraindications

As a precaution, patients have not been tested and should not be treated with Valeda if they have any known photosensitivity to yellow light, red light, or near-infrared radiation (NIR), or if they have a history of light-activated central nervous system disorders (e.g., epilepsy, migraine). In addition, patients should not receive treatment within 30 days of using photosensitizing agents (e.g., topicals, injectables) that are affected by 590, 660, and/or 850 nm light before consulting with their physician.

Contact us for more information about Valeda (336) 765-0960.